Izabela Domozych
Junior Quality Assurance Specialist at Celon Pharma S.A.- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Warsaw, Mazowieckie, Poland, PL
Topline Score
Bio
Generated by
Topline AI
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
You need to have a working account to view this content.
Click here to join now
Credentials
-
GMP w codziennej praktyce
WLR Training GroupMay, 2023- Sep, 2024 -
GMP od A do Z w wytwórni produktów leczniczych niesterylnych
WLR Training GroupApr, 2023- Sep, 2024 -
GMP dla wytwórców produktów leczniczych niesterylnych
WLR Training GroupMar, 2023- Sep, 2024 -
Wytwarzanie, dystrybucja i import substancji czynnych zgodnie z GMP, GDP i ustawą Prawo Farmaceutyczne
WLR Training GroupFeb, 2023- Sep, 2024
Experience
-
Celon Pharma S.A.
-
Poland
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Junior Quality Assurance Specialist
-
Dec 2022 - Present
-
-
-
-
DermaExpert Vichy, La Roche-Posay, CeraVe
-
Jun 2019 - Dec 2021
-
-
-
-
Asystent ds. badań aparaturowych
-
Jul 2018 - May 2019
-
-
-
Dr Irena Eris S.A.
-
Poland
-
Personal Care Product Manufacturing
-
200 - 300 Employee
-
Asystent ds. badań in-vivo
-
Jan 2018 - Jun 2018
-
-
-
-
Praktykantka
-
Sep 2017 - Sep 2017
Centrum Naukowo-Badawcze Centrum Naukowo-Badawcze
-
-
-
-
Praktykantka
-
Aug 2015 - Aug 2015
Zakład Analityki Badawczej Zakład Analityki Badawczej
-
-
Education
-
Uniwersytet Warszawski
Magister (Mgr), Chemia
Community
You need to have a working account to view this content.
Click here to join now
